drugset / Trial / NCT05775419

Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC

NCT05775419

RandomizedParallel-groupOpen-labelTreatment

Summary

This study is a phase III, multicenter, prospective randomized controlled clinical study comparing the efficacy of non-surgical esophageal squamous cell carcinoma with radical chemoradiotherapy and radical chemoradiotherapy combined with consolidation chemotherapy. The survival time and side effects of patients were observed and compared.

Timeline

Start
2021-06-30
Primary completion
2025-06-30
Completion
2028-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 75 mg/m2 Intravenous
Subject Paclitaxel liposome Unknown 135 mg/m2 Intravenous